Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-06-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine whether scores on questionnaires that rate how much Parkinson's Disease (PD) has slowed movements of the body differ when the order of the questions are changed. The consistency and accuracy of the questionnaires will also be examined. It is hypothesized that there will not be a difference.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease

NCT06301282

Parkinson Disease

RECRUITING

Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease

NCT00026598

Parkinson's Disease

COMPLETED

Cost-effectiveness of Nursing Interventions for Patients With PD

NCT03830190

Parkinson Disease

COMPLETED NA

Bringing Parkinson Care Back Home

NCT04288583

Parkinson Disease

UNKNOWN

Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily Life

NCT00184808

Parkinson's Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Full Exam

The first group will receive the full motor examination section in its original order.

Bradykinesia UPDRS Motor Full Examination

Intervention Type OTHER

The first group will receive the full motor examination section in its original order.

Subscale

The second group will receive the bradykinesia subscale first followed by the remainder of the motor examination section.

Bradykinesia subscale of UPDRS Motor Examination

Intervention Type OTHER

The second group will receive the bradykinesia subscale first followed by the remainder of the motor examination section.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bradykinesia UPDRS Motor Full Examination

The first group will receive the full motor examination section in its original order.

Intervention Type OTHER

Bradykinesia subscale of UPDRS Motor Examination

The second group will receive the bradykinesia subscale first followed by the remainder of the motor examination section.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Experimental group Subscale 1, Bradykinesia subscale

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or Female at least 30 years of age
2. Willing to be assessed using the motor examination section of the UPDRS and the SPES/SCOPA motor evaluation
3. Patients must be willing and able to give written informed consent prior to performing an study procedures
4. Be in the "ON" State (only for patients who fluctuate between "ON" and "OFF" states)

Exclusion Criteria

1. Absence of bradykinesia at the time of assessment
2. Hoehn and Yahr stage not available from patient's chart or not assessed between 3 and 180 days prior to clinic visit
3. Has received and experimental drug within the last thirty (30) days

Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No